Silverarc Capital Management »

Point Biopharma Global shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Point Biopharma Global shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Point Biopharma Global

Tip: Access up to 7 years of quarterly data

All positions including Point Biopharma Global held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Point Biopharma Global by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $625k 94k 6.67
2023-06-30 $849k 94k 9.06
2023-03-31 $1.4M 199k 7.27
2022-12-31 $2.9M 401k 7.29
2022-09-30 $2.3M 300k 7.73
2022-03-31 $1.6M 205k 7.97
2021-12-31 $1.1M 205k 5.60
2021-09-30 $552k 72k 7.70

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Point Biopharma Global

LMR Partners
Jet Capital Investors

View all funds holding Point Biopharma Global